Shenzhen Chipscreen Biosciences Co.,Ltd. Posted 24.3 Million Yuan Net Loss in First Three Quarters of 2021

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net loss of 24.3 million yuan in the first three quarters of 2021, reversing a net profit of 38.4 million yuan for the same period in the previous year.

Meanwhile, the company posted 276.5 million yuan in revenue, up 48.6% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 381 million yuan in total liabilities, with a liability-to-asset ratio of 21.9%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.